Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 EUR | +0.81% | -.--% | -.--% |
25/06 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
25/06 | Roche: approval of Ocrevus SC in Europe | CF |